Benralizumab (Fasenra)
Jump to navigation
Jump to search
No FDA approval for hematology/oncology conditions, at this time.
General information
Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).
Diseases for which it is used
Patient Drug Information
Also known as
- Brand names: Fasenra